Efficacy of Tianeptine 25-50 mg in Elderly Patients With Recurrent Major Depressive Disorder: An 8-Week Placebo- and Escitalopram-Controlled Study.

CONCLUSIONS: The present study provides robust evidence that an 8-week treatment period with tianeptine 25-50 mg is efficacious and well tolerated in depressed patients aged 65 years or older. TRIAL REGISTRATION: EudraCT identifier: 2012-005612-26. PMID: 29995359 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29995359?dopt=Abstract

Source: Journal of Clinical Psychiatry - July 12, 2018 Category: Psychiatry Tags: J Clin Psychiatry Source Type: research

More News: Depression | Lexapro | Psychiatry | Study